News & Updates
Filter by Specialty:

Does aspirin use improve outcomes in APS patients with arterial thrombosis?
The addition of low-dose aspirin to warfarin appears to increase the risk of major bleeding in patients with antiphospholipid syndrome (APS) but falls short in reducing all-cause mortality, according to a study presented at ASH 2025. Likewise, the rates of ischemic stroke and acute myocardial infarction are also higher among aspirin users.
Does aspirin use improve outcomes in APS patients with arterial thrombosis?
12 hours ago
Ivonescimab trumps tislelizumab for squamous NSCLC in HARMONi-6
In the phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly improved progression-free survival (PFS) compared with tislelizumab plus chemo as first-line treatment for individuals with advanced squamous non-small cell lung cancer (NSCLC).
Ivonescimab trumps tislelizumab for squamous NSCLC in HARMONi-6
14 hours ago
Real-world study supports high-dose IV iron for IBD-associated anaemia
Real-world evidence shows the efficacy and safety of high-dose intravenous (IV) iron for the treatment of anaemia in individuals with inflammatory bowel disease (IBD), irrespective of inflammatory activity.






